NCT00744549

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

The Impact of Antioxidants on MRI Markers of Cell Proliferation and Hypoxia Among Men on Active Surveillance With Early Stage Prostate Cancer

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: University Health Network, Toronto · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether antioxidants (vitamin E, selenium and lycopene)can change(reduce)prostate tumor size or blood flow to the prostate as determined by MRI imaging among men on Active Surveillance.

Conditions

• Cancer of the Prostate
• Prostate Cancer
• Prostatic Neoplasms

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E	Twice a day with meals. Lycopene - 20 mg, Vitamin D3 - 200 IU, Selenium - 100 mcg, Green Tea Extract - 75 mg, Vitamin E - 50 IU
DRUG	Placebo	Twice a day with meals.

Timeline

• Start date: 2008-05-01
• Primary completion: 2013-12-01
• Completion: 2013-12-01
• First posted: 2008-09-01
• Last updated: 2018-02-14

Locations

1 site across 1 country: Canada